Anika Therapeutics | ANIK - Koszty Operacyjne





Koszty Operacyjne Zmiana Data
Abbott USD 11.66B 1.2B 2026-09
Agenus USD -199.08M 22.15M 2026-06
Agios Pharmaceuticals USD 155.3M 24.53M 2026-06
Anika Therapeutics USD 137.28M 3.38M 2026-06
Arrowhead Research USD 245.35M 30.35M 2026-06
Enanta Pharmaceuticals USD 126.59M 346.51M 2025-12
Halozyme Therapeutics USD 198M 4.66M 2026-09
Heron Therapeutics USD 40.55M 1.46M 2025-12
Insmed USD 606.26M 79.46M 2026-09
Integra LifeSciences USD 368.53M 674.84M 2026-09
Intrexon USD 61.56M 26.1M 2024-06
J&J USD 18.93B 1.09B 2026-09
Karyopharm Therapeutics USD 61.83M 9.9M 2026-03
Ligand Pharmaceuticals USD 94.5M 39.4M 2026-09
MacroGenics USD 42.87M 21.68M 2026-06
Merit Medical Systems USD 358.44M 20.72M 2026-06
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sanofi EUR 10.51B 598M 2026-09
Smith & Nephew USD 2.59B 71M 2026-06
Stryker USD 4.8B 118M 2026-06
Veracyte USD 133.73M 7.37M 2026-09
Xencor USD 87.82M 5.44M 2026-06
Zimmer Biomet Holdings USD 1.72B 110.9M 2026-09